Skip to main content

Serevent Diskus News

FDA Medwatch Alert: Long-Acting Beta-Agonists (LABAs): New Safe Use Requirements

[UPDATED 04-15-2011] To further evaluate the safety of Long-Acting Beta-Agonists (LABAs) when used in combination with inhaled corticosteroids for the treatment of asthma, the FDA is requiring the...

FDA Medwatch Alert: Serevent Diskus (salmeterol xinafoate inhalation powder)

[Posted 11/18/2005] FDA notified manufacturers of Advair Diskus, Foradil Aerolizer, and Serevent Diskus to update their existing product labels with new warnings and a Medication Guide for patients...

FDA Medwatch Alert: Serevent (salmeterol xinafoate)

GlaxoSmithKline notified healthcare professionals of important new safety information on use of Serevent in patients with asthma. Recent findings from an interim analysis of a large Serevent safety...

FDA Medwatch Alert: Serevent Inhalation Aerosol and Diskus (salmeterol xinafoate)

The FDA announced the addition of new safety information and warnings to the labeling for drug products that contain salmeterol, a long-acting bronchodilator used to treat asthma and chronic...

Ask a question

To post your own question to our community, sign in or create an account.

Further information

Related condition support groups

Asthma - Maintenance

Serevent Diskus patient information at Drugs.com